| Salamanca Rehabilitation & Nursing Center | |
| 451 Broad Street, Salamanca, New York 14779 | |
| (716) 945-1800 | |
| Name | Salamanca Rehabilitation & Nursing Center |
|---|---|
| Location | 451 Broad Street, Salamanca, New York |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 120 |
| Occupancy Rate | 76% |
| Medicare ID (CCN) | 335534 |
| Legal Business Name | Absolut Center For Nursing And Rehabilitation At Salamanca, Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1023055902 |
| Organization Name | WOODLAND PARK HEALTHCARE CENTER, INC. |
| Doing Business As | THE WATERS OF SALAMANCA |
| Address | 451 Broad St, Salamanca, NY 14779 |
| Phone Number | 716-945-1800 |
News Archive
Cambridge Research & Instrumentation (CRi) has announced that the United States Patent Office has issued a notice of allowance for their patent application number 10/669,101, for Spectral Imaging of Deep Tissue.
Decades after undergoing cranial irradiation for childhood cancer, St. Jude Children's Research Hospital investigators found that adult survivors of pediatric cancer remain at risk for pituitary hormone deficiencies that may diminish their health and quality of life.
Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced the dosing of the first patient in a Phase I clinical study of AR-12 (formerly OSU-03012) in adult patients with advanced or recurrent solid tumors or lymphoma.
Older adults benefit from participating in community-based food and nutrition programs that enable them to remain healthy and independent, according to an updated position paper by the Academy of Nutrition and Dietetics and the Society for Nutrition Education and Behavior.
For the first time, next-generation DNA sequencing technologies have been turned on typhoid fever - a disease that kills 600,000 people each year. The results will help to improve diagnosis, tracking of disease spread and could help to design new strategies for vaccination.
› Verified 1 days ago
| NPI Number | 1144357963 |
| Organization Name | ABSOLUT CENTER FOR NURSING AND REHABILITATION AT SALAMANCA, LLC |
| Address | 451 Broad St, Salamanca, NY 14779 |
| Phone Number | 716-945-1800 |
News Archive
Cambridge Research & Instrumentation (CRi) has announced that the United States Patent Office has issued a notice of allowance for their patent application number 10/669,101, for Spectral Imaging of Deep Tissue.
Decades after undergoing cranial irradiation for childhood cancer, St. Jude Children's Research Hospital investigators found that adult survivors of pediatric cancer remain at risk for pituitary hormone deficiencies that may diminish their health and quality of life.
Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced the dosing of the first patient in a Phase I clinical study of AR-12 (formerly OSU-03012) in adult patients with advanced or recurrent solid tumors or lymphoma.
Older adults benefit from participating in community-based food and nutrition programs that enable them to remain healthy and independent, according to an updated position paper by the Academy of Nutrition and Dietetics and the Society for Nutrition Education and Behavior.
For the first time, next-generation DNA sequencing technologies have been turned on typhoid fever - a disease that kills 600,000 people each year. The results will help to improve diagnosis, tracking of disease spread and could help to design new strategies for vaccination.
› Verified 1 days ago
| NPI Number | 1700503240 |
| Organization Name | SARNC OPERATING LLC |
| Address | 451 Broad St, Salamanca, NY 14779 |
| Phone Number | 716-945-1801 |
News Archive
Cambridge Research & Instrumentation (CRi) has announced that the United States Patent Office has issued a notice of allowance for their patent application number 10/669,101, for Spectral Imaging of Deep Tissue.
Decades after undergoing cranial irradiation for childhood cancer, St. Jude Children's Research Hospital investigators found that adult survivors of pediatric cancer remain at risk for pituitary hormone deficiencies that may diminish their health and quality of life.
Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced the dosing of the first patient in a Phase I clinical study of AR-12 (formerly OSU-03012) in adult patients with advanced or recurrent solid tumors or lymphoma.
Older adults benefit from participating in community-based food and nutrition programs that enable them to remain healthy and independent, according to an updated position paper by the Academy of Nutrition and Dietetics and the Society for Nutrition Education and Behavior.
For the first time, next-generation DNA sequencing technologies have been turned on typhoid fever - a disease that kills 600,000 people each year. The results will help to improve diagnosis, tracking of disease spread and could help to design new strategies for vaccination.
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Cambridge Research & Instrumentation (CRi) has announced that the United States Patent Office has issued a notice of allowance for their patent application number 10/669,101, for Spectral Imaging of Deep Tissue.
Decades after undergoing cranial irradiation for childhood cancer, St. Jude Children's Research Hospital investigators found that adult survivors of pediatric cancer remain at risk for pituitary hormone deficiencies that may diminish their health and quality of life.
Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced the dosing of the first patient in a Phase I clinical study of AR-12 (formerly OSU-03012) in adult patients with advanced or recurrent solid tumors or lymphoma.
Older adults benefit from participating in community-based food and nutrition programs that enable them to remain healthy and independent, according to an updated position paper by the Academy of Nutrition and Dietetics and the Society for Nutrition Education and Behavior.
For the first time, next-generation DNA sequencing technologies have been turned on typhoid fever - a disease that kills 600,000 people each year. The results will help to improve diagnosis, tracking of disease spread and could help to design new strategies for vaccination.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 9.32 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.42 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 49.66 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.78 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.52 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.32 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0.93 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 91.61 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 12.18 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 18.71 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 6.25 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 20.86 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 17.45 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 10.57 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 70.65 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 66.03 | 82.93 |
News Archive
Cambridge Research & Instrumentation (CRi) has announced that the United States Patent Office has issued a notice of allowance for their patent application number 10/669,101, for Spectral Imaging of Deep Tissue.
Decades after undergoing cranial irradiation for childhood cancer, St. Jude Children's Research Hospital investigators found that adult survivors of pediatric cancer remain at risk for pituitary hormone deficiencies that may diminish their health and quality of life.
Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced the dosing of the first patient in a Phase I clinical study of AR-12 (formerly OSU-03012) in adult patients with advanced or recurrent solid tumors or lymphoma.
Older adults benefit from participating in community-based food and nutrition programs that enable them to remain healthy and independent, according to an updated position paper by the Academy of Nutrition and Dietetics and the Society for Nutrition Education and Behavior.
For the first time, next-generation DNA sequencing technologies have been turned on typhoid fever - a disease that kills 600,000 people each year. The results will help to improve diagnosis, tracking of disease spread and could help to design new strategies for vaccination.
› Verified 1 days ago
Salamanca Rehabilitation & Nursing Center Location: 451 Broad Street, Salamanca, New York 14779 Phone: (716) 945-1800 |